FIELD: medicine, ophthalmology, pediatrics.
SUBSTANCE: method involves apparatus treatment for 10 days with preliminary intramuscular administration of neuropeptide cortexin in the dose 5-10 mg, 10 injections. During apparatus treatment nootropic agent semax is administrated by intranasal route as instillations in the dose 1-2 drops, 2-3 times per 24 h for 10 days. Method provides improving eye memory, increasing rate in delivery and processing the eye information and the prolonged memory concentration necessary for effective apparatus method of treatment. Invention can be used in treatment of amblyopia in children with delayed intellectual development.
EFFECT: improved treatment method.
1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT OF GLAUCOMA OPTIC NEUROPATHY | 2006 |
|
RU2335283C2 |
METHOD OF DETERMINATION OF INDICATIONS FOR TREATMENT OF AMBLIOPY USING THE NEUROPEPTIDE PREPARATION | 2017 |
|
RU2647324C1 |
METHOD FOR TREATING THE CASES OF AMBLYOPIA | 2002 |
|
RU2205042C1 |
MEANS AND DEVICE FOR TREATING THE CASES OF OPTIC NERVE NEURITIS HAVING INFLAMMATORY, TOXICOALLERGIC OR VASCULAR ETIOLOGY AND OPTIC NERVE ATROPHY | 1999 |
|
RU2157258C1 |
METHOD OF TREATING VISUAL NERVE AND RETINAL DISEASES | 2010 |
|
RU2447864C1 |
METHOD OF COMBINED THERAPY OF INITIAL MYOPIA AND AMBLYOPIA IN CHILDREN | 2006 |
|
RU2324461C2 |
METHOD OF TREATING AMBLYOPIA IN CHILDREN | 2017 |
|
RU2648824C1 |
METHOD FOR TREATING CHILDREN FOR STRABISMIC AMBLYOPIA | 2005 |
|
RU2267339C1 |
METHOD FOR TREATING OPTIC NERVE DISEASES | 2001 |
|
RU2206299C2 |
METHOD OF TREATING GLAUCOMATOUS OPTIC NEUROPATHY | 2013 |
|
RU2546019C2 |
Authors
Dates
2006-03-27—Published
2004-08-19—Filed